Literature DB >> 19818805

Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task.

Panayotis K Thanos1, Iliyan Ivanov, John K Robinson, Michael Michaelides, Gene-Jack Wang, James M Swanson, Jeffrey H Newcorn, Nora D Volkow.   

Abstract

The spontaneously hypertensive rat (SHR) is a widely accepted rodent model of Attention Deficit/Hyperactivity Disorder (ADHD), and methylphenidate (MP) is a central nervous system stimulant that has been shown to have a dose-related positive effect on attention task performance in humans with ADHD. The current study was undertaken to compare SHR to its typical control strain, Wistar-Kyoto (WKY) rats, on the performance of a Visual Stimulus Position Discrimination Task (VSPDT) as well as of the responsiveness of the two rat strains to MP treatment. The rats were initially trained on the VSPDT, in which a light cue was presented randomly at three different cue-light intervals (1s, 300ms and 100ms) over one of two levers, and presses on the lever corresponding to the light cue were reinforced with a food pellet. Once rats reached stable performance, the treatment phase of the study began, during which they received daily intraperitoneal (IP) injections of saline, 2mg/kg, 5mg/kg, and 10mg/kg of MP in a randomized order immediately prior to being tested on the VSPDT. Baseline performance accuracy on the VSPDT did not differ between the groups. Furthermore, a striking strain dissociation was evident in the response of the two strains to treatment; VSPDT performance was substantially disrupted by the 5 and 10mg/kg dose in the WKY rats but only mildly in the SHR rats. Response omissions were also increased only in WKY rats. Finally, both strains had increased locomotor activity in the operant chamber following MP treatment. These findings point to an important difference in response tendency to MP in the two strains that supports a view that a critical difference between these strains may suggest neurochemical and neuroadaptive differences associated with the behavioral impairments of ADHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818805      PMCID: PMC3192027          DOI: 10.1016/j.pbb.2009.09.019

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  43 in total

1.  Attention deficit hyperactivity disorder in teens and adults: they don't all outgrow it.

Authors:  Robert J Resnick
Journal:  J Clin Psychol       Date:  2005-05

2.  Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD).

Authors:  Brent Alsop
Journal:  J Neurosci Methods       Date:  2006-12-16       Impact factor: 2.390

3.  Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  V A Russell; A S de Villiers; T Sagvolden; M C Lamm; J J Taljaard
Journal:  Brain Res Bull       Date:  2000-09-15       Impact factor: 4.077

4.  Nicotine treatment produces persistent increases in amphetamine-stimulated locomotor activity in periadolescent male but not female or adult male rats.

Authors:  Stephanie L Collins; Raquel Montano; Sari Izenwasser
Journal:  Brain Res Dev Brain Res       Date:  2004-11-25

5.  Assessing medication effects in the MTA study using neuropsychological outcomes.

Authors:  Jeffery N Epstein; C Keith Conners; Aaron S Hervey; Simon T Tonev; L Eugene Arnold; Howard B Abikoff; Glen Elliott; Laurence L Greenhill; Lily Hechtman; Kimberly Hoagwood; Stephen P Hinshaw; Betsy Hoza; Peter S Jensen; John S March; Jeffrey H Newcorn; William E Pelham; Joanne B Severe; James M Swanson; Karen Wells; Benedetto Vitiello; Timothy Wigal
Journal:  J Child Psychol Psychiatry       Date:  2006-05       Impact factor: 8.982

6.  Behavioural hyperactivity in rats following postnatal exposure to sub-toxic doses of polychlorinated biphenyl congeners 153 and 126.

Authors:  E Holene; I Nafstad; J U Skaare; T Sagvolden
Journal:  Behav Brain Res       Date:  1998-07       Impact factor: 3.332

7.  Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Arch Gen Psychiatry       Date:  1993-07

8.  Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  V Russell; A de Villiers; T Sagvolden; M Lamm; J Taljaard
Journal:  Brain Res       Date:  1995-04-10       Impact factor: 3.252

9.  Different effects of amphetamine on reinforced variations versus repetitions in spontaneously hypertensive rats (SHR).

Authors:  D M Mook; A Neuringer
Journal:  Physiol Behav       Date:  1994-11

10.  Behavioral reactivity in spontaneously hypertensive rats.

Authors:  E Hård; S G Carlsson; S Jern; K Larsson; A S Lindh; L Svensson
Journal:  Physiol Behav       Date:  1985-10
View more
  12 in total

1.  Individual and combined effects of physical exercise and methylphenidate on orienting behavior and social interaction in spontaneously hypertensive rats.

Authors:  Andrea M Robinson; David J Bucci
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

2.  Cross-fostering differentially affects ADHD-related behaviors in spontaneously hypertensive rats.

Authors:  Angela C Gauthier; Nicole E DeAngeli; David J Bucci
Journal:  Dev Psychobiol       Date:  2015-02-02       Impact factor: 3.038

3.  Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD).

Authors:  Mircea I Chelaru; Pamela B Yang; Nachum Dafny
Journal:  Behav Brain Res       Date:  2011-08-25       Impact factor: 3.332

4.  D-amphetamine improves attention performance in adolescent Wistar, but not in SHR rats, in a two-choice visual discrimination task.

Authors:  Jean-Charles Bizot; Nicolas Cogrel; Fabienne Massé; Virgile Chauvin; Léa Brault; Sabrina David; Fabrice Trovero
Journal:  Psychopharmacology (Berl)       Date:  2015-06-04       Impact factor: 4.530

5.  Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.

Authors:  Thomas E Wooters; Michael T Bardo
Journal:  Brain Res       Date:  2011-05-01       Impact factor: 3.252

6.  Detrimental effects of acute nicotine on the response-withholding performance of spontaneously hypertensive and Wistar Kyoto rats.

Authors:  Gabriel J Mazur; Gabriel Wood-Isenberg; Elizabeth Watterson; Federico Sanabria
Journal:  Psychopharmacology (Berl)       Date:  2014-01-11       Impact factor: 4.530

7.  Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasks.

Authors:  Richard Chu; Jed Shumsky; Barry D Waterhouse
Journal:  Brain Res       Date:  2015-12-10       Impact factor: 3.252

8.  Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder.

Authors:  Andrea M Robinson; Rachel L Eggleston; David J Bucci
Journal:  Behav Neurosci       Date:  2012-10-15       Impact factor: 1.912

9.  A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.

Authors:  Panayotis K Thanos; Lisa S Robison; Jessica Steier; Yu Fen Hwang; Thomas Cooper; James M Swanson; David E Komatsu; Michael Hadjiargyrou; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2015-01-29       Impact factor: 3.533

10.  Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments.

Authors:  Roxann C Harvey; Chloe J Jordan; David H Tassin; Kayla R Moody; Linda P Dwoskin; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.